Subvolts take AI found new antibiotics, tackling a global health crisis with practical, affordable methods. Oct 14, 2025 - Developers
- Learn how focused AI applications can achieve significant results with limited resources, applicable to drug discovery and beyond.
- Business
- Understand a practical AI success story in healthcare, demonstrating a clear path to addressing a major global crisis.
- Everyday users
- Discover how AI is being used to find new medicines and combat health threats like antibiotic resistance.
This interview features a leading researcher from MIT discussing a significant, real-world AI application with major humanitarian impact.
AI Discovered Antibiotics: How Small Data & Small GNNs Led to Big Results, w/ MIT Prof. Jim Collins
Audio streams from Erik Torenberg, Nathan Labenz. Your place is remembered on this device.
From Subvolts
Summary and analysis by Subvolts editorial, AI-assisted.
MIT Professor Jim Collins discusses his AI project that discovered new antibiotics effective against resistant bacteria. The method uses small datasets and modest compute to screen vast chemical spaces, offering an affordable path to combat antibiotic resistance. This practical AI application provides a significant win for humanity, distinct from AGI discussions.
Scientists used AI to find new medicines that fight superbugs, bacteria resistant to current drugs. This discovery offers a realistic way to address a major health threat that kills many people each year.
This episode details a tangible AI success story in drug discovery, a critical area for public health. It's for anyone interested in AI's real-world impact beyond theoretical advancements. The approach highlights how smaller, focused AI applications can yield significant results, contrasting with the massive scale often associated with frontier labs like Google Gemini or OpenAI.
- HostNathan Labenz
- GuestJim CollinsTermeer Professor, MIT
- Guest: Jim Collins, Termeer Professor at MIT
- Title: AI Discovered Antibiotics: How Small Data & Small GNNs Led to Big Results
- Show: The Cognitive Revolution
- Length: 85 minutes
- Antibiotic resistance impact: Claims over a million lives annually
Jim Collins, Termeer Professor at MIT, unveils his AI-powered project that has discovered several new antibiotics, effective against resistant strains and often employing entirely new mechanisms of action. He details how their refined multi-step AI process, even with small datasets and modest compute, can efficiently screen vast chemical spaces to identify promising drug candidates. This breakthrough offers a realistic and affordable path to tackling the staggering antibiotic resistance crisis, which currently claims over a million lives annually. Collins argues this practical application of AI represents a transformative win for humanity, often overlooked amidst the focus on AGI.
Sponsors:
AssemblyAI:
AssemblyAI is the speech-to-text API for building reliable Voice AI apps, offering high accuracy, low latency, and scalable infrastructure. Start building today with $50 in free credits at https://assemblyai.com/cognitive
Claude:
Claude is the AI collaborator that understands your entire workflow and thinks with you to tackle complex problems like coding and business strategy. Sign up and get 50% off your first 3 months of Claude Pro at https://claude.ai/tcr
Linear:
Linear is the system for modern product development. Nearly every AI company you've heard of is using Linear to build products. Get 6 months of Linear Business for free at: https://linear.app/tcr
AGNTCY:
AGNTCY is dropping code, specs, and services.
Visit AGNTCY.org.
Visit Outshift Internet of Agents
Shopify:
Shopify powers millions of businesses worldwide, handling 10% of U.S. e-commerce. With hundreds of templates, AI tools for product descriptions, and seamless marketing campaign creation, it's like having a design studio and marketing team in one. Start your $1/month trial today at https://shopify.com/cognitive
PRODUCED BY:
CHAPTERS:
(00:00) About the Episode
(04:30) Introducing Jim Collins
(05:26) Antibiotic Resistance Primer
(14:04) The Antibiotic Market Failure
(18:45) AI Discovers Halicin (Part 1)
(18:51) Sponsors: AssemblyAI Ad 1 | Claude
(22:11) AI Discovers Halicin (Part 2)
(30:58) The Economics of Discovery
(39:10) Inside the AI Architecture (Part 1)
(39:17) Sponsors: Linear | AGNTCY | Shopify
(43:47) Inside the AI Architecture (Part 2)
(01:00:13) Human-in-the-Loop Discovery
(01:12:12) Novel Mechanisms & Properties
(01:19:02) Future Applications & Risks
(01:27:01) A Call to Action
(01:28:04) Outro
- GNNs
- Jim Collins
- Graph Neural Networks, a type of AI that works well with data structured like networks.
1 h 27AI:AM: Where's the Steering Wheel? My Agent Set the Password, Hidden Valence, Proofs Find Linux Bugs
WithCameron Berg, Everett Hildenbrandt, Grigore Rosu, Phil Maher
2 h 192 h 021 h 28AI:AM: A Level We Shouldn't Pass? Notes from The Curve + Tokens vs. Salaries & Is SaaS Cooked?
WithThomas Sohmers, swyx, Evan Miyazono, Edward Hu
Questions people ask
- What did the AI project discover?
- The AI project discovered several new antibiotics effective against resistant bacterial strains, often with novel mechanisms of action.
- How does this AI approach work?
- It uses a refined, multi-step AI process that efficiently screens vast chemical spaces, even with small datasets and modest compute power.
Page generated Oct 19, 2026. Summaries are Subvolts' own; the audio, artwork and notes belong to Erik Torenberg, Nathan Labenz.